Financial Year |
March 31 2023 |
Monetary Funds |
274,968,790.34 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
23,696,315.36 |
Accounts Receivable |
469,262,461.70 |
Advances to Suppliers |
49,398,157.12 |
Other Receivables |
44,772,427.04 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
453,738,765.48 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
426,053,312.64 |
Total Current Assets |
1,756,788,903.29 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
-- |
Fixed Assetes |
227,284,505.55 |
Under-construction Projects |
1,071,356,372.86 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
201,727,561.83 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
350,618.91 |
Deferred Income Tax Assets |
20,418,944.10 |
Other Non-Current Assets |
17,163,716.88 |
Sub-Total of Non-Current Assets |
1,547,097,643.52 |
Total Assets |
3,303,886,546.81 |
Short-Term Loans |
366,531,733.55 |
Trading Financial liabilities |
-- |
Notes Payable |
319,975,565.43 |
Accounts Payable |
303,728,298.33 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
65,860,950.17 |
Taxes Payable |
265,382.64 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
122,452,272.16 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
71,704,740.92 |
Other Current Liabilities |
138,072,992.96 |
Sub-Total of Current Liabilities |
1,448,046,970.94 |
Long-term Loans |
276,096,660.92 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
759,536.96 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
372,899,668.47 |
Total Liabilities |
1,820,946,639.41 |
Paid-In Capital(Or Share Stock) |
245,090,000.00 |
Capital Surplus |
840,369,036.53 |
Surplus Reserve |
78,920,862.01 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
314,255,966.10 |
Minority Stockholder's Interest |
-- |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,482,939,907.40 |
Owner's Equity(Stockholder's Equity) |
1,482,939,907.40 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
3,303,886,546.81 |